463 related articles for article (PubMed ID: 18834953)
1. Use of DNA methylation for cancer detection: promises and challenges.
Zhu J; Yao X
Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
[TBL] [Abstract][Full Text] [Related]
2. Challenges for biomarkers in cancer detection.
Wagner PD; Verma M; Srivastava S
Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
Deng D; Liu Z; Du Y
Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and cancer diagnosis: new methods and applications.
Dehan P; Kustermans G; Guenin S; Horion J; Boniver J; Delvenne P
Expert Rev Mol Diagn; 2009 Oct; 9(7):651-7. PubMed ID: 19817550
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
8. CpG islands: their potential as biomarkers for cancer.
Shi H; Wang MX; Caldwell CW
Expert Rev Mol Diagn; 2007 Sep; 7(5):519-31. PubMed ID: 17892361
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
10. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of 14-3-3sigma in cancer.
Lodygin D; Hermeking H
Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome.
Suzuki H; Toyota M; Kondo Y; Shinomura Y
Methods Mol Biol; 2009; 512():55-69. PubMed ID: 19347273
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation: potential for diagnosis, prognosis and therapy--prediction in oncology].
Haedicke W; Lesche R
Verh Dtsch Ges Pathol; 2006; 90():39-45. PubMed ID: 17867578
[TBL] [Abstract][Full Text] [Related]
14. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
[TBL] [Abstract][Full Text] [Related]
15. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
Ahmed FE
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
Barton CA; Hacker NF; Clark SJ; O'Brien PM
Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
19. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
Verma M; Manne U
Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
